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Objectives: FIGO clinical staging, imaging techniques sometimes underestimate extension of 
locally advanced cervical cancer (LACC). The presence of para-aortic lymph node (LN) 
metastases in LACC identifies patients with poor prognosis. Laparoscopic para-aortic 
lymphadenectomy is now proposed as a diagnostic tool. Feasibility and safety of robot 
assisted laparoscopic para-aortic lymphadenectomy has been reported. We collected data 
from different Belgian centers to assess its oncological safety and complication rate. 
Study design: Three centers participated in the study. Thirty seven patients with LACC 
underwent a pre treatment robot assisted laparoscopic para-aortic lymphadenectomy. Data 
was prospectively collected. 
Results: The median number of LN collected was 27.5 (1-54) per patient. Five out of 37 
patients had para-aortic node metastasis. The false negative rate for PET CT diagnosing para-
aortic node metastasis was 10.8% (4/37). We encountered 2 major intra operative 
complications (5.4%). Post operative morbidity was low (13.5%). Median follow up was 27 
months (95% CI 24–30). Median disease free survival (DFS) was 16 months (95% CI 2.4-
29.6). Patients with negative LN had a median DFS of 24 months (NA) although patients with 
positive LN had a median DFS of 9 months (95% CI 6.9-11.9). 
Conclusions: In this series we report that robot assisted laparoscopic para-aortic 
lymphadencetomy provided the surgeon with useful information to avoid understaging in 
10.8% of women with LACC, at the expense of low morbidity (13.5%). Presence of 
microscopic para-aortic LN metastasis is correlated with shorter DFS. The number of patients 
with positive LN doesn’t allow us to draw any firm conclusion. 
 
